The novel hydroquinone, ( E )-2-(4-hydroxy-3-methyl-2-butenyl)-hydroquinone, and known compound, polyporenic acid C, were isolated as matrix metallo-proteinase inhibitors from the mushroom, Piptoporus betulinus.
Extracellular matrix (ECM) remodeling is essential to maintain tissue homeostasis in every organ of the body. Physiological ECM remodeling has been proposed to be mediated by members of the matrix metalloproteinases (MMPs).
1) Important members of these enzymes are collagenase (MMP-1), which cleaves all three alpha-chains of native interstitial collagens; 72 kDa gelatinase (MMP-2) and 92 kDa gelatinase (MMP-9), which cleave gelatin and the basement membrane; and stromelysin (MMP-3), which degrades a wider variety of protein substrates including gelatin,ˆbronectin, and laminin, as well as the core protein of cartilage proteoglycans. In addition, MMPs have been implicated in several pathological processes including arthritis, tumor growth, metastasis, periodontal disease, and multiple sclerosis. [2] [3] [4] [5] [6] Therefore, the discovery of potent inhibitors of these enzymes is a highly attractive endeavor both scientiˆcally and commercially.
In the course of screening for the inhibitory activity of mushroom extracts, we found that an extract of the mushroom, Piptoporus betulinus, inhibited MMPs. We describe here the isolation, structure and biological activity of the new inhibitor from this mushroom.
General experimental procedure. NMR spectra were measured by a Jeol Lambda-500 spectrometer and are given in ppm (d ) downˆeld from internal TMS. Mass spectra were recorded by a Jeol DX-302 mass spectrometer, and a Jasco grating infrared spectrophotometer was used to record the IR spectra. Extraction and isolation. Fresh fruiting bodies of P. betulinus (5.8 kg) were extracted with EtOH (10 l, 5 times), and the solution was concentrated under reduced pressure and partitioned between CHCl3 and H 2 O, and then between EtOAc and H 2 O. The residue (96.7 g) obtained after removing EtOAc was fractionated by silica gel ‰ash CC (90z, 60z CHCl3 W acetone; 70z, 50z CHCl3 W MeOH;, MeOH) to obtain 14 fractions. Fraction 10 (9.58 g) was further separated by reverse-phase HPLC (70z MeOH W H 2 O), giving 1 (3.0 mg). Compound 2 (3.0 mg) was obtained from fraction 8 (115 mg) by reverse-phase HPLC (90z MeOH W H2O).
MMP assay. DNA fragments coding the catalytic domain of human MMP-1 and human MMP-9 and a DNA fragment coding from the pro-domain to catalytic domain of human MMP-3 were ampliˆed by a polymerase chain reaction from cDNA of HT1080 cells that had been stimulated with 0.01 mM of phorbol 12-myristate 13-acetate (Sigma, St. Louis, MO, U.S.A.). The 5?-end of each PCR primer was added to a sequence for the appropriate restriction enzyme site. The ampliˆed DNA fragments were cloned into a cloning vector and then introduced into a commercially available expression vector containing His-6 tag sequence at the end of N-terminus. Recombinant proteins were expressed in Escherichia coli cells and puriˆed by Ni-NTA resin (Qiagen, Valencia, CA, U.S.A.) and refolded. Recombinant MMP-3 was activated by incubating with 1 mM p-aminophenylmercuric acetate (Sigma, St. Louis, MO, U.S.A.) for 1 h at 379 C. Each test compound was dissolved in DMSO and diluted with a reaction buŠer (50 mM Tris, 150 mM NaCl, 10 mM CaCl2, and 0.05z Brij-35 at pH 7.5). Twenty-ˆve ml of the compound solution was mixed with 25 ml of the diluted enzyme solution Scheme. 1
in a 96-well half-area black microplate (Costar) and incubated for 10 min at 379 C. The reaction was started by adding 50 ml of ‰uorescence-quenching peptide substrate solution to the well, and incubated for 2 (MMP-1 and MMP-3) or 3 (MMP-9) hours at 379 C. Five mM of MOCAc-Pro-Leu-Gly-Leu-A2pr(Dnp)-Ala-Arg-NH2 7) (Peptide Institute, Japan) was used as a substrate for MMP-1 and MMP-9, and 5 mM of MOCAc-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-ArgLys(Dnp)-NH2 8) (Peptide Institute, Japan) was used as a substrate for MMP-3. After the incubation, the ‰uorescence intensity (Ex W Em＝320 W 405 nm) of each well was measured by a ‰uorescence microplate reader (Polarstar; BMG LabTechnologies, Germany). IC50 values were calculated from the percentage inhibition by using GraphPad Prism (GraphPad Software, San Diego, CA, U.S.A.).
Compound 1: pale yellow oil; IR (neat) n max : 3243, 1456 cm "1 ; 1 H-and 13 C-NMR, Isolation was guided by the MMP-1 inhibition activity of eachfraction. Fresh fruiting bodies of P. betulinus were extracted with 85z EtOH. The extract, after concentrating the solvent, was partitioned between chloroform and water, and then between ethyl acetate and water. Since the EtOAc-soluble fraction showed inhibitory activity, this fraction was separated by repeated chromatography and HPLC to obtain compounds 1 and 2.
The molecular formula of compound 1 was determined to be C11H14O3 by HREIMS. , and H1? and H3?-Me in the NOESY spectrum indicated that the stereochemistry of the double bond in 1 was E. Thus, the structure of 1 was determined to be ( E )-2-(4-hydroxy-3-methyl-2-butenyl)-hydroquinone.
Compound 2 showed an ion peak at m W z 483 [M+H] + by FABMS. The NMR data for 2 agree with those of polyporenic acid C which has been reported as an MMP-1 inhibitor by us (IC50 of 126 mM).
9)
Compound 1 showed inhibitory activity against MMP-1 and its IC 50 value was 28 mM. This compound also inhibited MMP-3 (IC50 of 23 mM) and MMP-9 (IC50 of 37 mM).
